News Hub | News Direct

Consumer

Baby/Maternity Children Family LGBT Men Religion Teens Women
Article thumbnail News Release

NaRaYa Announced as Official Sponsor of APEC Voices of the Future 2022 Held in Thailand

NaRaYa

NaRaYa, a lifestyle brand that offers handbags and accessories to customers worldwide, has signed on as official sponsor of APEC Voices of the Future 2022, which will be held in Bangkok, Thailand in parallel with the APEC CEO Summit 2022 between November 13-18, 2022. Under this year’s theme, “Open. Connect. Balance.” with an emphasis on readiness to drive APEC forward to be open to all opportunities, connect in all dimensions, and balance in all aspects. NaRaYa is the sponsor of the APEC Voices of the Future 2022 program, as well as designing and producing a special bag collection for programme members and meeting attendees. On November 14, the company will host a special event at its headquarters for the delegates to attend. The APEC Voices of the Future program was first launched in 1998 in Kuala Lumpur, Malaysia. The event aims to provide opportunities for young people from 21 APEC economic zones to engage in activities that promote the exchange of perspectives and solutions on issues related to the future of economies in the Asia-Pacific region, where they discuss the challenging issues, opportunities, and solutions with the same objective as the APEC summit. Youth leaders will also be able to listen to the visions of executives from the world’s leading companies attending the APEC CEO summit. NaRaYa was founded in 1989, in Bangkok, Thailand by Mr. Vassilios Lathouras and Ms. Wasna Roongsaenthong. NaRaYa's products are artistically crafted, using high-quality materials to produce uniquely designed handbags and accessories at reasonable prices for everyone. The company is constantly developing products and expanding its product line to meet the ever-changing needs of consumers, while also supporting local communities across Thailand by providing job opportunities and generating income for locals. "We are delighted to be a part of the APEC Voices of the Future 2022 program, which provides a platform for the younger generation to have their voices heard and to showcase their full potential to the world, and we are honored to be a part of their journey,” said Pasin Lathouras, Chief Corporate Strategy Officer of NaRaYa. Lathouras added, “I firmly believe in providing opportunities for the new generation, and I’m inspired by what they are doing to make the world a more equal, sustainable, and greener place. More and more people are becoming aware of global issues that are occurring around the world, and the younger generation has become the forefront in raising these issues.” For more information about NaRaYa, please visit our website www.naraya.com For more information about APEC VOTF 2022, please visit www.apecvoicesofthefuture.org/ Contact Details NaRaYa Sakao Praditsuwan +66 66 113 4363 sakao.pr@naraya.com Company Website https://www.naraya.com/

November 15, 2022 10:30 AM Eastern Standard Time

Image
Article thumbnail News Release

Extreme Weather Puts Strain on Dairy Cows Across The Globe, Is Plant-Milk the Answer?

MarketJar

Extreme weather conditions across the globe are putting a strain on dairy cows, drying up milk production and withering crops that feed the cattle. Heat and drought in India, Australia and France are threatening long-term global dairy supply, including everything from butter to baby formula. Due to extreme weather brought on by climate change, some of the world's largest milk-producing regions are becoming less hospitable to these animals: Cows produce less milk when stressed by high temperatures, and arid conditions and storms exacerbate the problem by withering or destroying the grass and other crops they eat. In fact, some scientists predict that climate change will cost the dairy industry around $2.2 billion per year by the end of the century in the United States alone. According to another study, if greenhouse gas emissions remain high, the dairy and meat industries could lose $39.94 billion per year to heat stress by that same date. Fortunately, new and innovative alternative milk products are being developed for the market and consumers have been responding well. Plant-Based Milk Market Continues to Gain Steam Alternative dairy and plant-based milk are not new, but they have continued to rise in popularity over the years. In 2022, the plant-based milk market reached $38.9 billion after doubling in the previous five years. And over the next decade, the global market is expected to quadruple. As the market grows and evolves, new plant-based milk formulations are replacing old ones as consumer favorites. Soy milk was popular at first, but it gave way to almond milk. Now, oat milk is rapidly gaining popularity. Even as oat milk becomes more popular, a new plant-based milk trend is emerging: sesame milk. Some of the key factors behind the market's growth are the rising prevalence of dairy intolerance, as well as growing concern for the planet. Add to that increasing consumer awareness of the health of animals, and it’s easy to see why the plant-based milk industry is expected to continue rising in the coming years. Of course, alternatives like almond milk still take a toll on the planet due to high water usage and damage to bee populations. Luckily, there are new alternatives like sesame milk, which uses 95% less water compared to almond milk and thrives in arid climates around the globe, from South America to Africa to Asia. As consumers become more environmentally conscious, The Planting Hope Company Inc. (TSXV:MYLK) (OTCQB:MYLKF ) is gaining attention. The Planting Hope Company Inc. (TSXV:MYLK) (OTCQB:MYLKF) creates, introduces, and grows distinctively innovative plant-based and environmentally responsible food and beverage brands. Planting Hope 's innovative and award-winning products meet critical needs in the exploding plant-based food and beverage market. This rapidly growing company is focused on producing plant-based milk made from sustainable and highly nutritious sesame. The company's Sesame Milk has received numerous awards and nominations. Hope and Sesame Sesamemilk is just one of four fast-growing food and beverage brands owned by this company. The Planting Hope brand family includes RightRice® Veggie Rice, Mozaics(™) Real Veggie Chips, and Veggicopia® Veggie Snacks in addition to Hope and Sesame® (Sesamemilk and Barista Blend Sesamemilk). Planting Hope is a women-managed and women-led business with a focus on nutrition, sustainability, and diversity, founded by seasoned food industry entrepreneurs. Planting Hope Launches RightRice in Walmart Stores Across Canada The Planting Hope Company has already established and is expanding its relationships with major North American retailers and distributors, with products available in 8,500+ grocery stores and 50,000+ distribution points, including Whole Foods, Kroger, Sprouts Farmers Market, and others. The company has continued to execute its business plan since the beginning of 2022, expanding its core products in key channels as well as setting up new products and distribution that will reach scale in 2023. Earlier today, Planting Hope announced that its RightRice® Veggie Rice brand is launching in 180 Walmart stores across Canada, representing 720 new total distribution points (TDP). This marks the second major product launch in the Canadian market in the fourth quarter. “Walmart is an exciting place to launch RightRice in dual-language packaging to Canadian customers,” said Matt LeBeau, founder and CEO of LeBeau Excel Ltd., the company’s retail broker of record in Canada. “Walmart is increasing its focus on delivering plant-based and sustainable products to its shoppers, given increasing demand from Canadians for more nutritious and delicious food and beverages, and RightRice is a strong fit for that mission.” Planting Hope also recently announced the addition of RightRice® Veggie Rice and Hope and Sesame® Sesamemilk to Dot Foods, Inc.'s product line. The biggest foodservice re-distributor in North America, Dot, will soon stock award-winning Hope and Sesame® Barista Blend Sesamemilk in 32 oz shelf-stable cartons and Original RightRice® Veggie Rice in bulk 20lb bags. Hope and Sesame Sesamemilk Now Available in 382 Loblaw Stores in Canada in Dual-Language Packaging On November 8, Planting Hope launched its Hope and Sesame® Sesamemilk line in Canada with Loblaw Companies Limited, Canada's top grocery retailer. Hope and Sesame® Sesamemilk will be available in 382 Loblaw stores across Canada in November 2022 in Canadian-compliant dual-language packaging under multiple banners, including Loblaws, Fortinos, and Provigo. Packaged in shelf-stable 946ml (32oz) cartons in three flavors (Barista Blend Sesamemilk, Original Sesamemilk, and Unsweetened Original Sesamemilk), Hope and Sesame® Sesamemilk is now available in the plant milk section of Loblaw stores. Hope and Sesame® Sesamemilk offers Canadians delicious plant-based milk with vitamin, mineral, and protein content comparable to dairy milk. For more information on The Planting Hope Company (TSXV:MYLK) (OTCQB:MYLKF), please visit this link or their website at https://plantinghopecompany.com. Disclaimer 1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector. 2) The Article was issued on behalf of and sponsored by, The Planting Hope Company Inc. Market Jar Media Inc. has or expects to receive from The Planting Hope Company Inc.’s Digital Marketing Agency of Record (Native Ads Inc.) eighty eight thousand and seven hundred and eighty USD for 25 days (19 business days). 3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. Market Jar has not independently verified or otherwise investigated all such information. None of Market Jar or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy. Market Jar Media Inc.’s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on PressReach.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on PressReach.com. 5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article. 6) This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect management’s expectations regarding The Planting Hope Company Inc.’s future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to The Planting Hope Company Inc.’s industry; (b) market opportunity; (c) The Planting Hope Company Inc.’s business plans and strategies; (d) services that The Planting Hope Company Inc. intends to offer; (e) The Planting Hope Company Inc.s milestone projections and targets; (f) The Planting Hope Company Inc.s expectations regarding receipt of approval for regulatory applications; (g) The Planting Hope Company Inc.s intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) The Planting Hope Company Inc.s expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute The Planting Hope Company Inc.’s business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) The Planting Hope Company Inc.’s ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) The Planting Hope Company Inc.s ability to enter into contractual arrangements with additional Pharmacies; (e) the accuracy of budgeted costs and expenditures; (f) The Planting Hope Company Inc.s ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption to as a result of CV-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of The Planting Hope Company Inc.. to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) The Planting Hope Company Inc.s operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as CV-19 may adversely impact PThe Planting Hope Company Inc.’s business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing The Planting Hope Company Inc.’s business operations (e) The Planting Hope Company Inc. may be unable to implement its growth strategy; and (f) increased competition. Except as required by law, The Planting Hope Company Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither does The Planting Hope Company Inc. nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this document. Neither The Planting Hope Company Inc. nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this document by you or any of your representatives or for omissions from the information in this document. 7) Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of The Planting Hope Company Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of The Planting Hope Company Inc. or such entities and are not necessarily indicative of future performance of The Planting Hope Company Inc. or such entities. Contact Details James Young +1 800-340-9767 campaigns@pressreach.com Company Website https://pressreach.com

November 15, 2022 06:30 AM Pacific Standard Time

Image
Article thumbnail News Release

Women’s Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow

Agile Therapeutics, Inc.

Agile Therapeutics Inc. (NASDAQ: AGRX) is on a journey to fulfill the unmet health needs of women with products designed to provide them with contraceptive options. The company’s product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill without committing to a longer-acting method. Twirla® Agile ’s initial product Twirla® (levonorgestrel and ethinyl estradiol) transdermal system, is a nondaily prescription contraceptive based on the company’s proprietary transdermal patch technology called Skinfusion®, which is designed to allow drug delivery through the skin. The Twirla transdermal system is a once-weekly combined hormonal contraceptive (CHC) patch that contains the active ingredients levonorgestrel (LNG), a type of progestin, and ethinyl estradiol (EE), a type of estrogen. The patch is used as a contraceptive by women with a body mass index (BMI) less than 30 kilograms per meter (kg/m2) for whom a combined hormonal contraceptive is appropriate. It is less effective in women with a BMI of 25 or more. Q3 Financial Results And Corporate Update On Nov. 7, Agile released financial results for the three months that ended Sept. 30 and provided a corporate update. Financial Results Highlights: Net revenue: Twirla delivered $3.0 million in net revenue for the third quarter of 2022. This was an increase of 43% from the second quarter of 2022 – the largest quarter-over-quarter increase the Company has achieved. Cost of product revenue: Cost of product revenue totaled $1.4 million and consisted of direct and indirect costs related to the manufacturing of Twirla® sold, compared to $2.7 million for the third quarter of 2021 – a decrease of 47%. The decrease reflects the elimination of an inventory obsolescence reserve, which the company established in the third quarter of 2021. Total generally accepted accounting principles (GAAP) operating expenses: Total GAAP operating expenses were $20.3 million for the quarter that ended Sept. 30, compared to $14.4 million for the comparable period in 2021 — an increase of 41%. The GAAP operating expenses for the third quarter of 2022 represent an increase of 80% from the $11.3 million of GAAP operating expenses reported for the second quarter of 2022. Total non-GAAP operating expenses: Total non-GAAP operational expenditures were $9.2 million for the quarter that ended Sept. 30, compared to $14.4 million for the comparable period in 2021 — a decrease of 36%. The non-GAAP operating expenses for the third quarter decreased 19% from the $11.3 million non-GAAP operating expenses reported for the second quarter of 2022. The company had a one-time, non-cash charge associated with the transfer of equipment to Corium in the third quarter and believes the non-GAAP operating expense, which excludes this charge from GAAP operating expenses, presents a more useful comparison of the results from its operations because prior periods did not include a similar charge. The company provided a reconciliation of its GAAP operating expenses versus non-GAAP operating expenses in its press release. Cash: As of Sept. 30, the company had $6.1 million of cash, compared to $13 million of cash and cash equivalents as of the end of the second quarter of 2022. Net loss: Net loss was $19.7 million, or 53 cents per share for the quarter that ended Sept. 30, compared to a net loss of $16.8 million, or $7.20 per share, for the comparable period in 2021. The company incurred a one-time, noncash operating expense charge of $11.1 million in the third quarter of 2022 related to the transfer of equipment ownership to Corium Inc., which is reflected in the net loss for the third quarter of 2022. Shares outstanding: As of Sept. 30, Agile had 39,026,823 shares issued and 36,997,836 weighted average shares of common stock outstanding. Key Contributors To Future Growth Although the company reported a net loss for the quarter due to reasons that included extraordinary ones, it says it has an effective business plan in place and is tracking towards its goal of generating positive cash flow. An important contributor to the company’s third-quarter growth was its partnership with Afaxys Inc., which drove volume in the nonretail channel. In the second quarter of 2022, 1,404 nonretail cycles of Twirla®were purchased, and that number surged 361% in the third quarter to 6,479 nonretail cycles. “This growth is the product of the efforts being made by Afaxys to penetrate the Planned Parenthood network. In the third quarter, we began to see the conversion of Planned Parenthood accounts in California, which drove significant sales and growth for the quarter. We believe this represents a sustainable customer base for future periods,” Agile Therapeutics Chief Commercial Officer Amy Welsh said. She added that by focusing on five key states — California, Texas, Florida, Illinois, and New York — “It is estimated that we can reach 45% of U.S. women between the ages of 18 and 24. In the future, we expect the retail channel to continue to grow.” Additionally, Agile plans to launch its collaboration with female telehealth leader Nurx in the fourth quarter of 2022 and expects the collaboration to begin to contribute to retail channel growth in 2023. Nurx is a leader in female-focused digital healthcare amongst the Twirla target audience and offers patients access to its telehealth platform and expert medical providers that have prescribed contraception to more than 1 million patients Generating Positive Cash Flow In an industry with players like Dare Bioscience Inc. (NASDAQ: DARE) and Hologic Inc. (NASDAQ: HOLX), Agile is exploring business development opportunities that could potentially accelerate the timeline for generating positive cash flow. “Our stated plan has been to effectively manage expenses while continuing to grow Twirla® sales and demand. This is the third consecutive quarter we have increased Twirla® sales and demand while simultaneously decreasing company operating expenses, excluding the noncash, one-time charge incurred this quarter,” Chairman and CEO and Director of Agile Therapeutics Chairman and CEO Alfred Altomari said. “We are working — and have been working — to identify and implement strategies and exploit opportunities that will contribute to further growth,” he added. If Agile maintains its quarterly revenue growth rate and operating expenses consistent with the past two quarters, the company could potentially begin to generate positive cash flow at the end of 2023. The addition of a business development opportunity or partnership could potentially accelerate that timeline. Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Matt Riley - Head of Investor Relations & Corporate Communications mriley@agiletherapeutics.com Company Website https://agiletherapeutics.com/

November 15, 2022 08:15 AM Eastern Standard Time

Article thumbnail News Release

GETIR GOES BANANAS CELEBRTATING ONE YEAR U.S. ANNIVERSARY!

Getir

Getir, the pioneer of ultrafast grocery delivery, celebrates one year of launching in the United States in Chicago, New York, and Boston. Through its revolutionary last-mile grocery delivery service, the Getir app has been opened in the U.S. more than 40 million times, saving users over 700,000 hours. To celebrate, bananas, the most popular selling product on the U.S. app, are available for nine cents. According to data from the U.S. Bureau of Labor Statistics, the average cost of bananas is $0.64 per pound, approximately $0.21 each. “We are excited to be celebrating our one year anniversary in the United States. We are proud of this accomplishment and all of our teams who have made this first year in the United States successful,” said Langston Dugger, Head of US Operations. “American customers enjoy the convenience and reliability of our service and variety of our products.” A bunch of stats: Top Ten Selling Products Top Neighborhoods Chicago – River North Boston – Brookline New York – Lower East Side Distance Traveled Getir has fulfilled orders by traveling over 1.4 million zero-emission miles, equating to 402,000 pounds of CO2 emissions saved Our delivery team has clocked enough miles to travel around the world 57 times, three times to the moon and back Charitable Efforts Donated over 75,000 meals to local nonprofits Saved the equivalent of 8.9 million gallons of water through food donations About Getir: Getir is the pioneer of ultrafast grocery delivery. The tech company, based in Istanbul, has revolutionized last-mile delivery with its “groceries in minutes” delivery proposition, offering approximately 2,000 everyday items to its customers. Getir has operations in all 81 cities of Turkey, and launched operations in the UK, the Netherlands, Germany, France, Spain, Portugal and the United States in 2021. Learn more at www.getir.com/us. Contact Details Arielle Goren +1 212-717-5863 getir@kivvit.com Company Website http://www.getir.com/us

November 14, 2022 02:15 PM Eastern Standard Time

Article thumbnail Digital Asset Direct

Top Tech Gifts

News Media Group, Inc.

Contact Details Karl Wayne +1 334-440-6397 karl@newsmg.com Company Website https://newsmg.com/

November 14, 2022 11:30 AM Eastern Standard Time

Video
Article thumbnail News Release

Research Shows that Age Assurance Needs Clarity and Improvement

FOSI

The Family Online Safety Institute ( FOSI ) today released a new report, Making Sense of Age Assurance: Enabling Safer Online Experiences, which explores awareness and attitudes toward age assurance among parents and children in the United States, United Kingdom, and France. Age assurance ensures that users who do not meet age minimums cannot access online platforms, or must stay in age-appropriate environments. This new report found that age assurance methods are received with mixed perceptions, with respondents showing an openness to future solutions but also highlighting the need for education and transparency upon implementation. Key findings from the report captured levels of awareness among parents and children, outlooks on the use of biometric data, and cultural contrasts in parenting style. “Age assurance has long been a challenging area for the technology industry, as certain methods may also require the collection of more user data,” said Stephen Balkam, FOSI CEO. “This year’s report shows a clear opportunity to improve methods of age assurance, which must begin by helping people to understand it. This means providing clarity around the purpose of assuring age, how the process works, and how they benefit.” “At Google, we are committed to creating age-appropriate experiences to help kids and teens use technology in a safer and more privacy-protective environment,” said Markham Erickson, Vice President, Government Affairs & Public Policy, Google. “This research highlights the complexities associated with establishing the age of users and the importance of including the perspectives of both parents and their children in the discussion. We are proud to partner with FOSI on this critical work and will continue to collaborate on how to help kids and teens enjoy the benefits that technology has to offer when it comes to learning, staying connected and having fun.” Parents and responsibility Despite growing concerns about younger children accessing platforms while underage, this study found that most parents (53% in the US, 57% in the UK, and 49% in France) are willing to make an exception or allow their child to bypass an age requirement, though they then often require direct oversight of the account or discussions about how to use an app safely. While the majority of parents (74% in the US, 80% in the UK, and 73% in France) see themselves as the primarily responsible party for ensuring that their children interact with age-appropriate content, more than half of parents in each country surveyed agree that industry and government should both be more involved in protecting children. Future solutions Despite hypotheses that the use of biometric components may cause concerns around data privacy, this report found that respondents are open to age assurance methods that include it. Over two-thirds of parents and children in the US and UK, and roughly half in France, indicate that they are open to age assurance methods that include a biometric component. Nearly two-thirds of parents across all three countries feel that biometrics are an effective tool for assessing age. If offered, parents report that their most ideal method for setting age assurance on apps and services would be on a per account basis, the point at which they are downloaded from an app store. Country differences The report also finds that different social and cultural factors impact parenting styles and child-parent relationships in each country. US parents reported the highest amount of time spent monitoring their children’s online usage at 11.8 hours per week, in contrast with UK parents at 7.6 hours per week, and French parents at 3.5 hours per week. French parents are also the least likely to use tech tools such as monitoring software or apps to oversee their children’s online activities. 87% of US parents and 82% of UK parents have used such tools, compared to 65% in France. This study was supported by Google, and conducted by Kantar. Topline findings will be presented at the FOSI 2022 Annual Conference, Trust and Assurance: Online Safety in an Uncertain World. Each year, FOSI convenes the premier event in online safety, bringing together leaders from across industry, government, academia, and the nonprofit sector. This year’s agenda includes topics such as content moderation, privacy policy, safety in the metaverse, digital wellbeing, and more. The conference will feature remarks by FTC Commissioner Alvaro Bedoya, as well as the launch of the Global Online Safety Regulators Network, a new initiative seeking to encourage a collaborative approach to legislation globally. About FOSI The Family Online Safety Institute is an international, non-profit organization that works to make the online world safer for kids and their families. FOSI convenes leaders in industry, government and the non-profit sectors to collaborate and innovate new solutions and policies in the field of online safety. Through research, resources, events and special projects, FOSI promotes a culture of responsibility online and encourages a sense of digital citizenship for all. FOSI's membership includes many of the leading Internet and telecommunications companies around the world. Contact Details Curley Company for the Family Online Safety Institute Justin Siraj +1 202-505-0143 justin@curleycompany.com Company Website https://www.fosi.org/

November 14, 2022 08:00 AM Eastern Standard Time

Article thumbnail News Release

Fine Hygienic Holding Wins License to Market FIFA World Cup Qatar 2022™ Facial Tissues and Will Be Providing Hygiene Support During the Tournament

Fine Hygienic Holding

Football's world governing body FIFA has awarded Fine Hygienic Holding (FHH) the license to design, produce, and sell limited-edition packs of facial tissues commemorating the FIFA World Cup Qatar 2022™. FHH launched the special edition packs in hypermarkets and supermarkets in Jordan, Egypt, Saudi Arabia, the UAE, Bahrain, Oman, Kuwait, Iraq, Morocco, and Sudan in mid-September 2022. FHH will also be providing sanitation support at the tournament itself, working across the 8 stadiums, training sites, and FIFA Fan Festivals to ensure the highest level of hygiene for fans, teams, and players attending FIFA World Cup Qatar 2022™. Commenting on this occasion, James Michael Lafferty, FHH CEO, said, "“We at Fine are delighted to be supporting the hygiene program at the FIFA World Cup, and ensuring we help make this the most hygienically protected sports event since the pandemic. Our Fine Guard products, with long lasting germ protection, are a perfect solution for areas such as stadiums where constant foot traffic renders only brief disinfection with traditional products. Spectators and everyone involved can rest easy knowing FIFA is using state of the art products and technologies." The FIFA World Cup Qatar 2022™ will be the first World Cup ever to be held in the Arab World. It is scheduled to take place from November 20 to December 18, 2022, in Qatar, with matches being played across eight stadiums, hosting 32 teams. About Fine Hygienic Holding: Fine Hygienic Holding (FHH), one of the world's leading wellness groups and MENA's leading manufacturer of hygienic products, serves consumers in more than 80 countries around the world. Originally established as a paper manufacturer, FHH has transformed into a wellness company dedicated to enhancing global health and wellbeing. FHH offers a diverse array of award-winning products including sterilized facial tissues, napkins, kitchen towels, toilet paper, baby diapers, adult briefs, jumbo rolls, as well as away-from-home products to accommodate all types of private and public institutions, in addition to its advanced range of personal protective equipment (PPE) and long-lasting germ protection solutions, it also brings innovative nutritional supplements, Motiva, to the market. Contact Details FINE HYGIENIC HOLDING Rana Kawalit | │ Corporate Communication & PR Director +971 54 531 5575 Rkawalit@finehh.com Company Website https://www.finehh.com/

November 14, 2022 12:30 AM Eastern Standard Time

Article thumbnail News Release

SIGMA 18-50mm F2.8 DC DN | Contemporary Lens for FUJIFILM X Mount Announced

SIGMA CORPORATION OF AMERICA

SIGMA Corporation of America, the US subsidiary of SIGMA Corporation (CEO: Kazuto Yamaki. Headquarters: Asao-ku, Kawasaki-shi, Kanagawa, Japan) is pleased to announce the SIGMA 18-50mm F2.8 DC DN | Contemporary for FUJIFILM X Mount mirrorless cameras. This addition allows users to enjoy a high-performance, high-quality, compact standard zoom lens in native mount on their X Mount system. The announcement of the 18-50mm F2.8 DC DN | Contemporary expands the SIGMA lineup for X Mount, joining the three fast-aperture prime lenses, the 16mm F1.4 DC DN | Contemporary, 30mm F1.4 DC DN | Contemporary, and 56mm F1.4 DC DN | Contemporary, which were announced for the FUJIFILM X Mount platform earlier this year. The SIGMA 18-50mm F2.8 DC DN | Contemporary lens for FUJIFILM X Mount will retail for $549 and will be available through authorized retail partners in early December 2022. Learn more about the SIGMA 18-50mm F2.8 DC DN | Contemporary: https://www.sigmaphoto.com/18-50mm-f2-8-dc-dn-c #SIGMA #SIGMA1850mmContemporary #SIGMAContemporary #SIGMADCDN #SIGMAXMount SIGMA 18-50mm F2.8 DC DN|Contemporary in FUJIFILM X Mount Announced SIGMA Corporation is pleased to announce the launch schedule of SIGMA 18-50mm F2.8 DC DN | Contemporary for FUJIFILM X Mount. Supplied accessories: Petal-type hood (LH582-02), Front cap (LCF-55 III), Rear Cap (LCR II) Mount: FUJIFILM X Mount Launch: December 2022 * The appearance and specifications of the product are subject to change. A large F2.8 aperture zoom lens that need never leave your camera This exceptionally light, bright, and sharp standard zoom for crop-sensor mirrorless cameras is the ultimate workhorse lens. Long-awaited X Mount addition SIGMA's first APS-C size mirrorless dedicated zoom lens, the 18-50mm F2.8 DC DN | Contemporary, will now be available for FUJIFILM X Mount. This addition allows users to enjoy high-performance, and high-quality SIGMA zoom lenses in native mount on their X Mount system. The first three lenses in SIGMA's X Mount lineup were the wide-angle prime 16mm F1.4 DC DN | Contemporary, the standard prime 30mm F1.4 DC DN | Contemporary, and the telephoto prime 56mm F1.4 DC DN | Contemporary. The lineup consists of focal lengths making a complete system for mirrorless camera users. Now, with the addition of the 18-50mm F2.8 DC DN | Contemporary, a compact, lightweight, and high-performance large-aperture standard zoom lens, SIGMA offers a new option for this compact photographic system. A control algorithm including AF drive and communication speed optimization has been developed specifically for X Mount interchangeable lenses. In addition to realizing high-speed AF, the lens also supports AF-C (Continuous AF) and in-camera aberration correction*. The mount is rubber-sealed to cater for use in a variety of environments. * Available on supported cameras only. Mount Conversion Service is available to convert other mounts of SIGMA 18-50mm F2.8 DC DN | Contemporary to FUJIFILM X Mount. [Key Features] Large F2.8 aperture and superb image quality The compact body offers an easy-to-use zoom range of 27mm to 75mm in the 35mm format, a wide aperture of F2.8 throughout the entire zoom range that allows you to enjoy bokeh expressions, and sharp images achieved by the latest optical design technology. With a minimum focusing distance of 12.1cm and a maximum magnification of 1:2.8 *1, it allows photographers to take advantage of the compact shooting system, such as shooting close-ups of your subject. Exceptionally compact and lightweight body ideal for mirrorless cameras The main feature of the 18-50mm F2.8 DC DN | Contemporary is its overwhelmingly compact and lightweight body that maximizes the excellent portability and advantages of an APS-C mirrorless camera. Despite its large aperture of F2.8, it is the smallest and lightest in its class *2 boasting a maximum diameter of 61.6mm, a length of 76.8mm and weight of 285g. *3 This makes the large-aperture standard zoom easy to carry around in daily life. *1 The minimum focusing distance and maximum magnification ratio are both values at the wide end. *2 As an AF compatible, F2.8 constant aperture zoom lens for APS-C (as of October 2022, by SIGMA). *3 Size and weight measurements given for X Mount version. [Key Specifications] The figures below are for X Mount: Lens construction: 10 groups, 13 elements (1 SLD and 3 aspherical lenses) Angle of view (APS-C): 76.5° (W) - 31.7° (T) Number of diaphragm blades: 7 (rounded diaphragm) Minimum aperture: F22 Minimum focusing distance: 12.1 (W) - 30 (T) cm / 4.8 (W) - 11.9 (T) in. Maximum magnification ratio: 1:2.8 (W) - 1:5 (T) Filter size: 55mm Dimensions (Max. Diam. x Length): 61.6 x 76.8mm / 2.4 x 3.0 in. Weight: 285g / 10.1 oz. [Contact] For further information, please contact your local authorized SIGMA Service Station listed here: https://www.sigma-global.com/en/world-network/ [Information] SIGMA GLOBAL VISION: https://www.sigma-global.com/ SIGMA 18-50mm F2.8 DC DN | Contemporary product information: https://www.sigma-global.com/en/lenses/c021_18_50_28/ SIGMA X Mount special page: https://www.sigma-global.com/en/magazine/m_series/others-lenses/fujifilm-x-mount/sigma_xmount_lenses/ About SIGMA Corporation Craftsmanship. Precision. Dedication. Since 1961, SIGMA has been devoted to the pursuit of advancing photographic technology. Unique to the industry, the family-owned business produces its high-quality, award-winning still photo and cinema camera lenses, DSLR and mirrorless cameras, flashes, filters and accessories from its state-of-the-art manufacturing facility located in Aizu, Japan. In 2012, the company introduced SIGMA Global Vision with three distinct lens lines: Art, Contemporary and Sports. Designed for industry camera mount systems including Canon, Leica, Nikon, Olympus, Panasonic, Sony and SIGMA, each lens is handcrafted and tested in Japan to ensure a high-performance, premium product that is purpose-built to last. In 2016, the SIGMA Cine lens lineup was launched, further cementing SIGMA as an innovator in imaging engineering. Embodying the core optical DNA that has defined the SIGMA benchmark of excellence, SIGMA Cine lenses meet the needs of advanced 6k and 8k cinema production. Forming the landmark L-Mount alliance alongside Leica and Panasonic in 2018, SIGMA continues its storied tradition of imaging excellence through groundbreaking innovations such as the native L-mount SIGMA fp and fp L full-frame mirrorless digital cameras, announced in July 2019 and March 2021 respectively. These products, along with nearly 30 award-winning SIGMA Global Vision lenses available in native L-Mount format, demonstrate SIGMA's continued commitment to the creative community through expanded product offerings. With the fp, fp L and these lenses, even more users can now leverage SIGMA's renowned optical formula to achieve their creative vision with ease. For information about SIGMA America, please visit sigmaphoto.com and SIGMA Blog for helpful information about our products. Follow SIGMA America on social media! SIGMA Photo: Facebook, Twitter and Instagram SIGMA Cine: Facebook, Twitter and Instagram Contact Details SIGMA +1 631-201-7381 SIGMA.PR@Sigmaphoto.com Company Website https://www.sigma-global.com/en/

November 14, 2022 12:01 AM Eastern Standard Time

Image
Article thumbnail News Release

Fall Health Checklist from the College of American Pathologists

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/DotHvhg8XQw Summer is coming to a close, which means it’s the perfect time to take stock of your health and set yourself up for success the rest of the year. The FDA has recently changed their guidelines regarding Covid at-home tests, now advising people to take three tests, instead of the previously recommended two tests. The agency issued the update just ahead of the back-to-school season – an attempt to reduce the risk of infection being missed and to help people from unknowingly spreading the virus. But COVID isn’t the only thing on people’s minds. With fall approaching, cold and flu season isn’t far behind. This time of year can create confusion for people who may not be able to tell the difference between COVID symptoms and cold/flu symptoms. There are also concerns about the spread of Monkeypox and the re-emergence of Polio. During a nationwide media tour on September 15 th, Dr. Emily Volk – President of the College of American Pathologists discussed: Changing FDA guidelines around COVID testing and what you need to know Navigating flu shots and COVID boosters Tips for knowing the difference between COVID symptoms and cold/flu symptoms Additional insights on recent health concerns such as Monkeypox and Polio For more information, visit CDC.GOV or FDA.GOV Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

November 11, 2022 10:31 AM Eastern Standard Time

Video
1 ... 105106107108109 ... 186